CrushSCI.com
57.8Average days
49Median days
1Fastest days
196Longest days
222025 publications

Paper Review Records

All Paper Review Records

12 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

80 days

Thrombotic and Hemorrhagic Events in Myeloproliferative Neoplasms

Authors
Kari Brown; Douglas TremblayShow moreShow less
Affiliations
1. Hematology/Oncology Section, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, USAShow moreShow less
Source PDF DOI Publisher page
196 days

Approach to Patients with Multiple Myeloma after BCMA targeted Therapy

Authors
Hanne Marie Norseth; Rakesh Popat; Fredrik SchjesvoldShow moreShow less
Affiliations
1. Oslo University Hospital; 2. University of Oslo; 3. University College London Hospitals NHS Foundation TrustShow moreShow less
Source PDF DOI Publisher page
49 days

Impact of Germline DNA Repair Mutations on Clonal Hematopoiesis and Myeloid Neoplasm Development

Authors
Kateryna Fedorov; Leo Y. Luo; Alexander G. Bick; Michael R. SavonaShow moreShow less
Affiliations
1. Vanderbilt-Ingram Cancer Center, Nashville, US; 2. Division of Hematology and Oncology, Department of Medicine, Nashville, US; 3. Vanderbilt School of Medicine, Vanderbilt University Medical Center, Nashville, US; 4. Department of Radiation Oncology, Nashville, US; 5. Division of Genetic Medicine, Department of Medicine, Nashville, USShow moreShow less
Source PDF DOI Publisher page
48 days

Targeting RUNX1 Germline Variants: Agents Under Investigation

Authors
Saman Ghalamkari; Christopher N. Hahn; Amelia Lau; Hamish S. Scott; Claire C. Homan; Anna L. BrownShow moreShow less
Affiliations
1. Centre for Cancer Biology, SA Pathology, University of South Australia, Adelaide, Australia; 2. Department of Genetics and Molecular Pathology, SA Pathology, Adelaide, Australia; 3. Adelaide Medical School, The University of Adelaide, Adelaide, AustraliaShow moreShow less
Source PDF DOI Publisher page
1 days

The Evolving Therapeutic Landscape of Richter Transformation

Authors
Henry Le; Grace Baek; Ivan Huang; Chloe Siu; Mazyar ShadmanShow moreShow less
Affiliations
1. Department of Pharmacy, Fred Hutchinson Cancer Center, Seattle, USA; 2. Department of Pharmacy, University of Washington Medical Center, Seattle, United States; 3. Department of Cellular Immunotherapy, Fred Hutchinson Cancer Center, Seattle, USA; 4. Division of Hematology and Oncology, University of Washington School of Medicine, Seattle, USAShow moreShow less
Source PDF DOI Publisher page
17 days

Transforming the Treatment of Acute Lymphoblastic Leukemia: the Role of Bispecific Antibodies, Antibody-Drug Conjugates, and CAR T-cell Therapy

Authors
Tala Najdi; Sarah Khanfour; Joe Chalhoub; Shereen Sakkal; Fadi G. Haddad; Hampig Raphael KourieShow moreShow less
Affiliations
1. Department of Hematology-Oncology, Hotel-Dieu de France University Hospital, Beirut, Lebanon; 2. Saint Joseph University of Beirut, Beirut, Lebanon; 3. Faculty of Medicine, University of Montreal, Quebec, Canada; 4. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, USAShow moreShow less
Source PDF DOI Publisher page

FAQ

How long does Current Hematologic Malignancy Reports take to review a manuscript?

As of 2026-11-19, CrushSCI has 12 complete review records for Current Hematologic Malignancy Reports. The fastest paper went from submission to acceptance in 1 days (The Evolving Therapeutic Landscape of Richter Transformation, received 2025-11-02, accepted 2025-11-03); the slowest took 196 days. The average is 57.8 days and the median is 49 days. The fastest record has an unusually short interval; please check the original source.

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

We will reply within 30 minutes.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review59.6 days

Median65 days

Contact CrushSCI

Contact CrushSCI

Leave your email address to discuss academic polishing, structural refinement, or one-to-one guidance.

We will reply within 30 minutes.

Selected service: Academic Consulting Service

Leave your email address

Or email us directly at leader@crushsci.com

Enter your email address so we can reply. Your details will remain private.